We provide 1 form of Selumetinib
Selumetinib
606143-52-6
|
457.681
|
3.88
Selumetinib is a MEK 1/2 (Dual specificity mitogen-activated protein kinase kinase 1/ 2) inhibitor used in pediatric patients to treat neurofibromatosis type 1 accompanied by symptomatic, inoperable plexiform neurofibromas.
ARRY-142886 | AZD6244 | refametinib | selumetinib
Selumetinib is a MEK 1/2 (Dual specificity mitogen-activated protein kinase kinase 1/ 2) inhibitor used in pediatric patients to treat neurofibromatosis type 1 accompanied by symptomatic, inoperable plexiform neurofibromas.
ARRY-142886 | AZD6244 | refametinib | selumetinib
$240/5 mg
(EBC)
1
We provide 0 compound for Selumetinib